Literature DB >> 7762060

Normalization of circadian blood pressure profiles after renal transplantation.

C D Gatzka1, H P Schobel, A U Klingbeil, H H Neumayer, R E Schmieder.   

Abstract

Most patients with secondary hypertension due to renal disease or on maintenance hemodialysis have lost the physiologic fall of blood pressure during sleep. To test the notion that kidney transplantation normalizes the blood pressure profile, we monitored ambulatory blood pressure over 24 hr in 45 patients (29 males and 16 females) after successful renal transplantation. The longer the time after renal transplantation, the more marked was the decrease of blood pressure during sleep (r = 0.38, P < 0.01). This effect of time after renal transplantation on the fall of blood pressure during sleep was independent of the prevailing level of 24-hr ambulatory blood pressure. The prevalence of dippers (defined by a fall in mean blood pressure during sleep of 10% or more of the awake mean) increased from 27% in the early phase (< 7 months) to 73% in the late phase (> or = 1 year) after renal transplantation (P < 0.01). Again, this effect was not attributable to the level of 24-hr ambulatory blood pressure and concomitant antihypertensive or immunosuppressive medication. We conclude that renal transplantation leads to a normalization of the circadian blood pressure profile with a marked decrease of blood pressure during sleep. As a consequence, the lower hemodynamic load imposed on the cardiovascular system may in turn lead to a reduction of cardiovascular morbidity and mortality.

Entities:  

Mesh:

Year:  1995        PMID: 7762060

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  15 in total

Review 1.  Twenty four hour ambulatory blood pressure monitoring: a new tool for determining cardiovascular prognosis.

Authors:  K Madin; P Iqbal
Journal:  Postgrad Med J       Date:  2006-09       Impact factor: 2.401

2.  Assessment of long-term cardiovascular effects of unilateral nephrectomy.

Authors:  Sultan Ozkurt; Yusuf Karavelioglu; Macit Kalcik; Ahmet Musmul
Journal:  Int Urol Nephrol       Date:  2017-03-04       Impact factor: 2.370

3.  Desoxycorticosterone pivalate-salt treatment leads to non-dipping hypertension in Per1 knockout mice.

Authors:  K Solocinski; M Holzworth; X Wen; K-Y Cheng; I J Lynch; B D Cain; C S Wingo; M L Gumz
Journal:  Acta Physiol (Oxf)       Date:  2016-10-03       Impact factor: 6.311

Review 4.  Circadian rhythm of blood pressure in renal disease.

Authors:  M Schömig; V Schwenger; E Ritz
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

5.  Night blood pressure responses to atenolol and hydrochlorothiazide in black and white patients with essential hypertension.

Authors:  Arlene B Chapman; George Cotsonis; Vishal Parekh; Gary L Schwartz; Yan Gong; Kent R Bailey; Stephen T Turner; John G Gums; Amber L Beitelshees; Rhonda Cooper-DeHoff; Eric Boerwinkle; Julie A Johnson
Journal:  Am J Hypertens       Date:  2013-07-25       Impact factor: 2.689

Review 6.  The circadian clock in the kidney.

Authors:  Lisa R Stow; Michelle L Gumz
Journal:  J Am Soc Nephrol       Date:  2011-03-24       Impact factor: 10.121

Review 7.  Regulation of circadian blood pressure: from mice to astronauts.

Authors:  Rajiv Agarwal
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-01       Impact factor: 2.894

8.  The circadian clock protein Period 1 regulates expression of the renal epithelial sodium channel in mice.

Authors:  Michelle L Gumz; Lisa R Stow; I Jeanette Lynch; Megan M Greenlee; Alicia Rudin; Brian D Cain; David R Weaver; Charles S Wingo
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

Review 9.  Circadian clock-mediated regulation of blood pressure.

Authors:  Lauren G Douma; Michelle L Gumz
Journal:  Free Radic Biol Med       Date:  2017-12-02       Impact factor: 7.376

10.  Volume-associated ambulatory blood pressure patterns in hemodialysis patients.

Authors:  Rajiv Agarwal
Journal:  Hypertension       Date:  2009-06-15       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.